✦ LIBER ✦

Dactinomycin in the Treatment of Recurrent or Persistent Endometrial Carcinoma: A Phase II Study of the Gynecologic Oncology Group

✍ Scribed by David H. Moore; John A. Blessing; Charles Dunton; Richard E. Buller; Gary C. Reid

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Anastrozole in Advan

✍ Peter G. Rose; Virginia L. Brunetto; Linda VanLe; Jeffrey Bell; Joan L. Walker; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Phase II Trial of Pyrazoloacridine in Pa

✍ Steven C. Plaxe; John A. Blessing; Nader Husseinzadeh; Kenneth D. Webster; Janet 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 39 KB

A phase II study of gemcitabine (gemzar,

✍ David L. Tait; John A. Blessing; James S. Hoffman; Kathleen N. Moore; Nick M. Sp 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 151 KB

A phase II evaluation of weekly docetaxe

✍ Agustin A. Garcia; John A. Blessing; Susan Nolte; Robert S. Mannel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Phase II trial of combination bevacizuma

✍ E. Alvarez; W. Brady; J. Walker; J. Rotmensch; X. Zhou; J. Kendrick; S. Yamada; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Phase II trial of combination bevacizuma

✍ Alvarez, Edwin A.; Brady, William E.; Walker, Joan L.; Rotmensch, Jacob; Zhou, X 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 236 KB